key: cord-0727380-ll3bnvsv authors: Schneider, William M.; Luna, Joseph M.; Hoffmann, H.-Heinrich; Sánchez-Rivera, Francisco J.; Leal, Andrew A.; Ashbrook, Alison W.; Le Pen, Jérémie; Michailidis, Eleftherios; Ricardo-Lax, Inna; Peace, Avery; Stenzel, Ansgar F.; Lowe, Scott W.; MacDonald, Margaret R.; Rice, Charles M.; Poirier, John T. title: Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks date: 2020-10-08 journal: bioRxiv DOI: 10.1101/2020.10.07.326462 sha: 351c5fea4c313cdb8e47b1926ebb5b26cc70cc9f doc_id: 727380 cord_uid: ll3bnvsv The COVID-19 pandemic has claimed the lives of more than one million people worldwide. The causative agent, SARS-CoV-2, is a member of the Coronaviridae family, which are viruses that cause respiratory infections of varying severity. The cellular host factors and pathways co-opted by SARS-CoV-2 and other coronaviruses in the execution of their life cycles remain ill-defined. To develop an extensive compendium of host factors required for infection by SARS-CoV-2 and three seasonal coronaviruses (HCoV-OC43, HCoV-NL63, and HCoV-229E), we performed parallel genome-scale CRISPR knockout screens. These screens uncovered multiple host factors and pathways with pan-coronavirus and virus-specific functional roles, including major dependency on glycosaminoglycan biosynthesis, SREBP signaling, and glycosylphosphatidylinositol biosynthesis, as well as an unexpected requirement for several poorly characterized proteins. We identified an absolute requirement for the VTT-domain containing protein TMEM41B for infection by SARS-CoV-2 and all other coronaviruses. This human Coronaviridae host factor compendium represents a rich resource to develop new therapeutic strategies for acute COVID-19 and potential future coronavirus spillover events. HIGHLIGHTS Genome-wide CRISPR screens for SARS-CoV-2, HCoV-OC43, HCoV-NL63, and HCoV-229E coronavirus host factors. Parallel genome-wide CRISPR screening uncovered host factors and pathways with pan-coronavirus and virus-specific functional roles. Coronaviruses co-opt multiple biological pathways, including glycosaminoglycan biosynthesis, SREBP signaling, and glycosylphosphatidylinositol biosynthesis and anchoring, among others. TMEM41B - a poorly understood factor with roles in autophagy and lipid mobilization - is a critical pan-coronavirus host factor. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 pandemic, has claimed the lives of more than one million people worldwide in a span of nine months (Zhou et al., 2020; Zhu et al., 2020a) , (https://coronavirus.jhu.edu/map.html). SARS-CoV-2 is a betacoronavirus from the Coronaviridae family, which is composed of enveloped positive-sense RNA viruses with large (> 30kb) genomes that can infect a variety of vertebrate hosts (Cui et al., 2019) . Seasonal human coronaviruses (HCoVs), such as the HCoV-OC43 betacoronavirus, as well as the HCoV-NL63 and HCoV-229E alphacoronaviruses, can cause mild to moderate upper-respiratory infections with cold-like symptoms in humans (Cui et al., 2019) . In stark contrast, highly pathogenic betacoronaviruses have been responsible for multiple deadly outbreaks in the 21st century, including severe acute respiratory syndrome coronavirus (SARS-CoV, 2003) , Middle East respiratory syndrome coronavirus (MERS-CoV, 2012) , and SARS-CoV-2 (2019) (Cui et al., 2019) . The spread of SARS-CoV and MERS-CoV was contained, in part due to their comparatively low transmissibility (Cui et al., 2019) . However, SARS-CoV-2 spreads more readily and remains largely uncontrolled across the globe, presenting an urgent health crisis. A complete understanding of the host factors and pathways co-opted by SARS-CoV-2 and other coronaviruses for the execution of their life cycles could contribute to the development of therapies to treat COVID-19 and increase preparedness for potential future outbreaks. Large scale forward genetic approaches based on RNA interference, insertional mutagenesis, and CRISPR have proven powerful for identifying host factors required for infection by different viruses (reviewed in (Puschnik et al., 2017) ). Here, we performed parallel genome-scale CRISPR-Cas9 knockout screens to generate an extensive functional catalog of host factors required for infection by SARS-CoV-2 and three seasonal coronaviruses (HCoV-OC43, HCoV-NL63, and HCoV-229E). We identified multiple genes and pathways with pan-coronavirus and virus-specific functional roles, including factors involved in glycosaminoglycan (GAG) biosynthesis, sterol regulatory element-binding protein (SREBP) signaling, and glycosylphosphatidylinositol (GPI) biosynthesis, as well as several poorly characterized proteins, such as Transmembrane Protein 41B (TMEM41B). We show that the VMP1, TMEM41, and TVP38 (VTT)-domain containing protein TMEM41B is a critical host factor required for infection by SARS-CoV-2, HCoV-OC43, and HCoV-229E, as well as several flaviviruses of high interest to public health (Hoffmann & Schneider et al., ; see accompanying manuscript), thereby nominating it as a broadspectrum RNA virus liability and potential high-priority target for future drug development efforts. We set out to develop an extensive catalog of human host factors required for infection by the pandemic SARS-CoV-2 strain and three seasonal coronaviruses (HCoV-OC43, HCoV-NL63 and HCoV-229E) (Cui et al., 2019) ( Figure 1A) . We employed high-throughput CRISPR-Cas9 genetic screening using the well-established Brunello genome-wide library, which is composed of 76,441 single guide RNAs (sgRNAs) targeting 19,114 human genes (Doench et al., 2016a) . As a screening platform, we used Cas9-expressing Huh-7.5 hepatoma cells (Huh-7.5-Cas9), which endogenously express the SARS-CoV-2 cellular receptor, angiotensin-converting enzyme 2 (ACE2), as well as transmembrane serine protease 2 (TMPRSS2), a key mediator of SARS-CoV-2 entry (Hoffmann et al., 2020b) . We recently showed that Huh-7.5-Cas9 cells are permissive to infection by SARS-CoV-2, HCoV-OC43, HCoV-NL63, and HCoV-229E, and that they are a robust system for CRISPR-based genetic screening (Hoffmann et al., 2020a) . We performed a series of parallel genetic screens by transducing Huh-7.5-Cas9 cells with the Brunello sgRNA library followed by antibiotic selection and expansion for seven days to ensure homogeneous CRISPR-based knockout of host factor genes prior to infection with the panel of coronaviruses. In this context, cells expressing sgRNAs targeting genes required for virus infection or virus-induced death should survive while those expressing neutral sgRNAs or sgRNAs targeting genes irrelevant to infection are expected to deplete. Similarly, cells expressing sgRNAs targeting essential genes with no roles in virus infection or virus-induced death are expected to deplete in both "mock" (uninfected) and virusinfected conditions. SARS-CoV-2 screens were performed in triplicate at two physiologically relevant temperatures, 33 ºC and 37 ºC, to mimic the temperatures of the upper and lower airways, respectively (V'kovski et al., 2020) . Surviving cells were harvested five days post-infection and subjected to genomic DNA extraction and screen deconvolution using high-throughput sequencing (Hoffmann et al., 2020a) . Several quality control (QC) metrics demonstrated excellent technical performance across all screens and biological replicates ( Figure S1 ). First, we confirmed that 76,160/76,441 (99.6%) of sgRNAs from the Brunello library were recovered from the plasmid preparation and that all screen libraries were sequenced to saturation ( Figure S1A) . Second, pairwise correlation analyses demonstrated that biological replicates from each genetic screen clustered together and shared a high correlation coefficient ( Figure S1B) . Third, receiver operating characteristic (ROC) curves generated based on the fitness effects of disruption of previously defined neutral and essential genes from the Brunello library confirmed robust gene disruption in the cell pools ( Figure S1C-D) . The HCoV-229E screen, though successful, was particularly stringent, resulting in a lower area under the curve (AUC) relative to the other screens in this study. As described in our recent study (Hoffmann et al., 2020a) , we performed a z-score analysis as well as gene essentiality (beta) score using a published maximum likelihood estimation (MLE) algorithm (Li et al., 2014) . The gene essentiality analysis allowed us to stratify candidate host factor targets based on their effects on cellular fitness under mock (uninfected) conditions followed by the identification of high-confidence gene hits in virus-infected cells. Specifically, genes with beta scores similar to essential genes could affect cell survival in the presence or absence of infection and may be confounded by effects on cellular fitness. Conversely, genes with beta scores similar to neutral sgRNAs are predicted to affect cell survival only during viral infection and are more likely to be true positives. We implemented these parameters into our analysis pipeline and identified 146 and 171 genes that significantly influenced SARS-CoV-2-induced cell death at 37 ºC and 33 ºC, respectively (FDR < 0.05) (summarized in Figure 1B -E, Figure S2B -C, and Table S1A-B). These included the SARS-CoV-2 receptor ACE2 and the well known host factor cathepsin L (CTSL) (Hoffmann et al., 2020b; Letko et al., 2020; Yeager et al., 1992) . MERS-CoV receptor DPP4 (Earnest et al., 2017; Wang et al., 2013) and putative SARS-CoV-2 receptors KREMEN1 and ASGR1 did not score in any of these screens (Gu et al., 2020) . (Figure S2A) . A total of 84 (37 ºC) and 99 (33 ºC) genes scored as candidate host factors that may facilitate SARS-CoV-2 infection (z-score > 0; FDR < 0.05). Conversely, 62 (37 ºC) and 72 (33 ºC) genes scored as candidate antiviral host factors (z-score < 0; FDR < 0.05). As expected, neutral and essential gene-targeting sgRNAs scored similarly across mock and SARS-CoV-2 conditions (blue and red dots in Figure S2B -C, respectively). Integrating the 33 ºC and 37 ºC SARS-CoV-2 screening datasets allowed us to obtain a clearer picture of candidate temperaturespecific host factors that either support or antagonize SARS-CoV-2 viral infection ( Figure 1D -E and Figure S2D ). These results demonstrate that the human genome encodes a catalog of host factors that functionally contribute to the SARS-CoV-2 life cycle. Viruses within the same family often require the same host factors to complete their respective life cycles (Dimitrov, 2004) . Nevertheless, there are several examples of closely related viruses with discrete host factor requirements. For example, while SARS-CoV-2 and HCoV-NL63 both engage ACE2 as a cellular receptor, HCoV-229E uses ANPEP while HCoV-OC43 has no known essential proteinaceous receptor (Cui et al., 2019; Forni et al., 2017) . Beyond attachment factors and receptors, closely related viruses can also exploit specific components of multiple intracellular pathways in a virusspecific manner. For example, we recently reported that SARS-CoV-2 appears to rely on the RAB10 and RAB14 small GTPases whereas HCoV-229E, HCoV-OC43, and HCoV-NL63 mainly require RAB2A and RAB7A (Hoffmann et al., 2020a) . A comprehensive functional understanding of the commonalities and differences among coronaviruses and other virus families could pave the way for both specific and general antiviral therapies. Towards this goal, we significantly expanded our functional genomics efforts to develop an extensive functional catalog of human host factors required for infection by members of the Coronaviridae family, including two alphacoronaviruses (HCoV-NL63 and HCoV-229E) and one additional betacoronavirus (HCoV-OC43). The results of these three additional CRISPR screens are shown in Figure 2A -C, Figure S3 and Table S1C -E. An integrative analysis that also includes the two SARS-CoV-2 screens described above is shown in Figure 2D . Taken together, these screens identified numerous coronavirus-specific and pancoronavirus host factors that appear to play critical roles during infection by each of these viruses. This extensive network of human host factors functionally implicates numerous cellular pathways, as shown in Figure 3A . We present a selection of comparative analyses below that highlight both pan-coronavirus and virus-specific host factors through the lens of SARS-CoV-2. The SARS-CoV-2 and HCoV-OC43 betacoronaviruses co-opt a significantly overlapping set of host factors to carry out their life cycles. These include proteins involved in pathways related to GAG biosynthesis (e.g., heparan sulfate) and transport, such as EXT1, EXT2, EXTL3, B3GALT6, B3GAT3, B4GALT7, SLC35B2, XYLT2, HS2ST1, and NDST1 (Aikawa et al., 2001; Bai et al., 2001; Casanova et al., 2008; Cuellar et al., 2007; Kitagawa et al., 1998; Kreuger and Kjellén, 2012; Lind et al., 1998; Okajima et al., 1999; Ponighaus et al., 2007) . We also identified multiple factors that regulate intracellular protein trafficking, processing, and sorting through the cis-oligomeric Golgi (COG) complex, including COG2, COG3, COG4, COG7, and COG8 (Blackburn et al., 2019; Smith and Lupashin, 2008) ( Figure 3A,D,G) . Consistent with the role of heparan sulfate as an attachment factor for multiple viruses, the heparan sulfate biosynthesis pathway has been previously implicated as a critical host pathway for several viruses and virus families, including herpes simplex virus (O'Donnell and Shukla, 2008) , human papillomavirus (Giroglou et al., 2001; Joyce et al., 1999) , respiratory syncytial virus (Bourgeois et al., 1998; Escribano-Romero et al., 2004; Feldman et al., 2000; Hallak et al., 2000; Harris and Werling, 2003; Karger et al., 2001; Krusat and Streckert, 1997; Martinez and Melero, 2000; Techaarpornkul et al., 2002 ), adenoviruses (Dechecchi et al., 2001 Dechecchi et al., 2000) , hepatitis C virus (Xu et al., 2015) , dengue and Zika virus (Cruz-Oliveira et al., 2015; Marceau et al., 2016; Savidis et al., 2016) , West Nile virus (Perera-Lecoin et al., 2013) , Rift Valley fever virus (Riblett et al., 2016) , Eastern equine encephalitis virus (Gardner et al., 2011) , and HIV (Ibrahim et al., 1999) , among others. These studies support the central functional role of heparan sulfate proteoglycans and other glycosaminoglycans as common mediators of binding and entry for many viruses. Indeed, recent cellular and biochemical evidence suggests that SARS-CoV-2 exploits heparan sulfate proteoglycans cooperatively with ACE2 to bind to and gain entry into cells (Clausen et al., 2020b) . Given that no protein has been identified as a cellular receptor for HCoV-OC43 entry, it is possible that this betacoronavirus engages one or more GAGs to invade target cells. Another set of top-scoring factors in common between the SARS-CoV-2 and HCoV-OC43 screens were related to cholesterol homeostasis, particularly those related to SREBP cleavage-activating protein (SCAP)-mediated cholesterol sensing and the SREBP pathway ( Figure 3A -B, Figure S4A -B). Indeed, genes known to be functionally involved in the sensing and biosynthesis of cholesterol, such as SCAP, SREBF2 (but not SREBF1), MBTPS1, MBTPS2, and SAR1A were among the top enriched genes for these two viruses (Figure 3A-B) . These results are consistent with our recent discovery that SARS-CoV-2 and other coronaviruses require SCAP, NPC2, and EMC1 to carry out their life cycle (Hoffmann et al., 2020a) and extend these findings to further elaborate the essential regulatory components of SREBP signaling. We also note a unique reliance by HCoV-OC43 on factors involved in the synthesis of GPI anchored proteins (Figure 3A,C) . Collectively, these results nominate factors involved in GAG biosynthesis and transport, intracellular protein trafficking, processing, and sorting, and cholesterol homeostasis as potential targetable factors to inhibit SARS-CoV-2 and HCoV-OC43. We also identified host factors and pathways that appear to be required for SARS-CoV-2 infection but less so for other coronaviruses tested. Genes that participate in the mevalonate pathway, which is regulated by SREBP and is responsible for converting mevalonate into sterol isoprenoids, such as cholesterol (Buhaescu and Izzedine, 2007; Goldstein and Brown, 1990) , were among the top scoring hits ( Figure 3A ,B, Figure S4A , Figure S5A ). Multiple sgRNAs targeting 3-Hydroxy-3-Methylglutaryl-CoA Synthase 1 (HMGCS1), which catalyzes the conversion of HMG-CoA to mevalonic acid, mevalonate kinase (MVK), which catalyzes the phosphorylation of mevalonic acid into phosphomevalonate, and phosphomevalonate kinase (PMVK), which converts phosphomevalonate to mevalonate 5-diphosphate, were significantly enriched in SARS-CoV-2 screens, although to a lesser extent than SREBP signaling ( Figure 3A ,B and Figure S5A ). These results suggest that factors and intermediates of the mevalonate pathway, which are known to play important roles in post-translational modification of many proteins involved in key processes, such as intracellular signaling and protein glycosylation (Buhaescu and Izzedine, 2007; Goldstein and Brown, 1990) , are important for the life cycle of SARS-CoV-2. Another set of top-scoring genes in SARS-CoV-2 screens encode multiple subunits of the exocyst complex, which regulates the tethering of secretory vesicles to the plasma membrane and their subsequent SNARE-mediated membrane fusion and exocytosis (Martin-Urdiroz et al., 2016; Wu and Guo, 2015) (Figure 3G ). Multiple sgRNAs targeting EXOC1, EXOC2, and EXOC4 were significantly enriched, suggesting a critical role for these factors in mediating SARS-CoV-2 infection and virusinduced cell death. The mammalian exocyst complex is known to interact with specific RAB GTPases to coordinate intracellular trafficking (Babbey et al., 2010; Mei and Guo, 2018) . Indeed, sgRNAs targeting RAB6A and RAB10 were also among the most significantly enriched hits in SARS-CoV-2 screens (Figure 3) , a finding that is consistent with our recent work identifying RAB10 as a putative SARS-CoV-2-specific host factor (Hoffmann et al., 2020a) . These results suggest that SARS-CoV-2 relies on specific intracellular host factors and complexes that govern intracellular transport. Another complex that appears to play an essential role in the SARS-CoV-2 life cycle is the Mediator complex (Figure 3 and Figure S5B ). The mammalian Mediator is an evolutionarily conserved protein complex composed of at least 28 subunits that regulates transcription by functionally connecting general transcription factors with the core transcriptional machinery (Allen and Taatjes, 2015) . The Mediator subunits MED10, MED12, MED15, MED16, MED23, and MED24 were among the top-scoring genes in SARS-CoV-2 screens, suggesting a critical role for this complex during infection and death by this virus (Figure 3) . Intriguingly, a non-overlapping set of Mediator subunits was recently implicated in HIV-1 replication, including MED6, MED7, MED11, MED14, MED21, MED26, MED27, MED28, and MED30 (Ruiz et al., 2014) , suggesting that different viruses might have specific requirements for members of this complex during transcription and replication of their genomes. Beyond well-characterized pathways that were represented by multiple components, we also identified factors with less understood network-level connections ( Figure 3A ). These include the EMC genes ( Figure S5C ), DEAH-Box helicases DHX36 and DHX38, Golgin family proteins GOLGA6L1 and GOLGA8O, the General Transcription Factor IIIC subunits GTF3C5 and GTF3C6, tRNA methyltransferases TRMT5 and TRMT6, G protein-coupled receptors GPR89A and GPR89B, Transmembrane P24 trafficking proteins TMED2 and TMED10, and genes involved in phosphatidylethanolamine biosynthesis, such as PCYT2 and EPT1, among others ( Figure 3A and Table S1 ). Further mining of SARS-CoV-2 host factor networks could expand the repertoire of potential targetable factors to treat COVID-19. Given the genome-scale depth of this screening data, we sought to determine if interactome focused networks were significantly enriched in a genome-wide context. A recent SARS-CoV-2 CRISPR screen in an African green monkey Vero-E6 cells (Wei et al., 2020) failed to detect significant enrichment from a SARS-CoV-2-human protein-protein network derived from IP-MS (Gordon et al., 2020) . We recently tested genes from this protein-protein interactome with a focused CRISPR screen and assigned functional relevance to numerous members (Hoffmann et al., 2020b) . In our genome scale screens, we subsetted z-scores from the full interactome in Gordon et al., and detected a modest significant enrichment for hits in a genome-wide context ( Figure S5D) . Upon subsetting the functionally relevant members from our focused screen in Hoffmann et al., we observed a striking increase in significance ( Figure S5D ). The subsetted heatmap of hits in Hoffmann et al., mapped onto genome scale data largely cross validated many, but not all of our prior key findings ( Figure S5E ). These results demonstrate the power and utility of focused CRISPR screens to complement the breadth of genomewide efforts. Interestingly, the catalog of host factors essential for infection by the HCoV-NL63 and HCoV-229E alphacoronaviruses is significantly different than that of betacoronaviruses (Figure 2, Figure 3A , and Figure S4C -D). Furthermore, these viruses apparently rely on substantially different pathways to carry out their life cycles. Consistent with the literature, both screens successfully identified the cognate virus receptors, as evidenced by robust enrichment of sgRNAs targeting ACE2 (HCoV-NL63) and ANPEP (HCoV-229E) (Hoffmann et al., 2020b; Letko et al., 2020; Yeager et al., 1992) (Figure 2 and Figure 3 ). Intriguingly, HCoV-NL63 seems to rely on a core set of host chromatin regulators with known functional interactions, including EP300, KDM6A (also known as UTX), KMT2D (also known as MLL4), MED23, MED24, MEN1, PAXIP1, and SETDB1. This raises the tantalizing possibility that HCoV-NL63 co-opts the well established UTX-MLL4-EP300 enhancer remodeling network (which also contains PAXIP1) (Wang et al., 2017) to reprogram the host transcriptome for successful infection ( Figure 3A orange nodes). In addition, we observed a requirement for factors involved in BMP signaling with HCoV-NL63 specific factors SMAD4, SMAD5, ACVR1, and BMPR1A ( Figure 3F) . Lastly, our screening results suggest that HCoV-229E is particularly dependent on members of the HOPS complex, including VPS11 and RAB7A ( Figure 3A ) (Balderhaar and Ungermann, 2013) . Collectively, our results demonstrate that even closely related viruses, such as the HCoV-NL63 and HCoV-229E alphacoronaviruses, can employ markedly different host factor pathways during infection. As shown in Figure 1B -E, Figure 2 , and Figure 3A , sgRNAs targeting TMEM41B were among the most significantly enriched sgRNAs across the SARS-CoV-2, HCoV-OC43, and HCoV-229E screens. TMEM41B is a poorly understood ER-localized transmembrane protein that was recently implicated in the autophagy pathway (Moretti et al., 2018; Morita et al., 2018; Shoemaker et al., 2019) . Specifically, TMEM41B deficiency was shown to lead to accumulation of ATG proteins, thereby blocking the autophagy pathway at the early step of autophagosome formation. In addition, TMEM41B deficiency was shown to trigger the abnormal accumulation of intracellular lipid droplets. These phenotypes have been linked to the function of another autophagy factor, vacuole membrane protein 1 (VMP1), which shares a rare and characteristic VTT domain (Morita et al., 2019) . Interestingly, multiple sgRNAs targeting VMP1 were significantly enriched in the HCoV-229E screen ( Figure 2C ) while there was a trend towards enrichment in the SARS-CoV-2 screens that did not meet the cutoff for statistical significance due to variability between replicates. These findings prompted us to look into the autophagy network across all coronavirus screens in more detail. TMEM41B was the only autophagy-related gene that scored as a significant hit across our multiple coronavirus screens while only a handful of genes involved in the nucleation and tethering steps scored for HCoV-OC43 and HCoV-299E ( Figure 4A ). This was a striking finding given that we concurrently identified TMEM41B as a critical host factor for infection by multiple biosafety level three (BSL3) and BSL4 members of the Flaviviridae family, including 1) the mosquito-borne flaviviruses Zika virus, yellow fever virus, West Nile virus, and dengue virus, 2) the tick-borne flaviviruses Powassan virus, tick-borne encephalitis virus, Kyasanur forest disease virus, Omsk hemorrhagic fever virus, and Alkhurma hemorrhagic fever virus, and 3) other members of the Flaviviridae, including hepatitis C virus from the hepacivirus genus and bovine viral diarrhea virus from the pestivirus genus (Hoffmann & Schneider et al., ; see accompanying manuscript) . Comparative analyses between one such flavivirus, Zika, and SARS-CoV-2 screens suggested that TMEM41B is the only host factor that is critical for infection by both viruses (Figure 4B ) (Hoffmann & Schneider et al., ; see accompanying manuscript). Indeed, genetic disruption of TMEM41B was sufficient to render cells resistant to infection by SARS-CoV-2 and all of the seasonal coronaviruses and, importantly, infectivity could be reconstituted by TMEM41B cDNA expression ( Figure 4C ). Interestingly, TMEM41B sub-cellular localization changed dramatically upon infection by SARS-CoV-2 ( Figure 4D ). While mock-infected cells exhibited a diffuse reticular-like pattern of TMEM41B localization in the cytoplasm, cells infected with SARS-CoV-2 were characterized by large TMEM41B cytosolic aggregates and positive immunostaining for SARS-CoV-2 NS4A and NS4B viral proteins ( Figure 4D ). Thus, TMEM41B is a critical host factor required for infection by coronaviruses and several other pathogenic viruses and represents an attractive target for further intensive study. The full complement of human proteins and pathways required for infection by SARS-CoV-2 remains poorly defined. A more complete understanding of the cellular and molecular mechanisms that are coopted by coronaviruses could catalyze drug development efforts to combat the ongoing COVID-19 pandemic and prepare for potential future outbreaks. We performed parallel genome-scale CRISPR-Cas9 knockout screens to generate the most extensive functional catalog of host factors required for infection by SARS-CoV-2 and three seasonal coronaviruses (HCoV-OC43, HCoV-NL63, and HCoV-229E) reported to date ( Figure 3A and Table S1 ). This catalog contains multiple host factors and pathways that play critical pan-coronavirus and virus-specific functional roles ( Figure 3A ). We identified a profound requirement for factors involved in GAG (e.g., heparan sulfate) biosynthesis, transport, and modification during infection by the SARS-CoV-2 and HCoV-OC43 betacoronaviruses. These results suggest that HCoV-OC43 might engage one or more GAGs to invade target cells, and support recent studies showing that SARS-CoV-2 simultaneously co-opts heparan sulfate proteoglycans and ACE2 to gain entry into cells (Clausen et al., 2020a) . Of note, HS2ST1, a component of the heparan sulfate biosynthetic pathway, was identified in the present study as well as in our prior work (Hoffmann et al., 2020a) . These results nominate factors involved in GAG biosynthesis, modification, and transport as potential targetable factors to inhibit SARS-CoV-2 and HCoV-OC43. We also identified proteins that mediate cholesterol homeostasis via SREBP signaling as key host factors for infection by SARS-CoV-2 and HCoV-OC43. These results agree with and substantially extend results from our recent functional interactome study demonstrating that SARS-CoV-2 and other coronaviruses require SCAP, NPC2, and EMC1 to carry out their life cycles and elucidate the essential regulatory components of SREBP signaling (Hoffmann et al., 2020a) . In addition, these results are consistent with work on several other viruses, including Ebola virus (Carette et al., 2011) and hantavirus (Kleinfelter et al., 2015) , among others. Beyond SREBP signaling, we also identified three of the key enzymes from the mevalonate pathway (HMGCS1, MVK, and PMVK), which is responsible for converting mevalonate into sterol isoprenoids, such as cholesterol ( Figure 3A , Figure 3B , Figure S4A ). Given that statins -one of the most widely used class of drugs in the world -block mevalonate production via inhibition of the HMGCoA reductase and have been recently associated with improved outcomes among COVID-19 patients (Fajgenbaum and Rader, 2020; Zhang et al., 2020) , it is tempting to speculate that pharmacological modulation of the mevalonate pathway could be a promising strategy for treating COVID-19. Another set of critical host factors for SARS-CoV-2 infection are involved in regulating intracellular transport, tethering, and exocytosis of secretory vesicles, including RAB GTPases ( Figure 3A, Figure S4E ). These results lend further support to our recent nomination of RAB10 as a putative SARS-CoV-2 host factor (Hoffmann et al., 2020a) and suggest that different coronaviruses might have differential requirements or preferences for intracellular transport proteins. We also uncovered an unexpected robust dependency on the Mediator complex ( Figure 3A , Figure S4B ). Intriguingly, a non-overlapping set of Mediator subunits was recently implicated in HIV-1 replication (Ruiz et al., 2014) , suggesting that different viruses might have specific requirements for members of this complex during transcription and replication of their genomes. Therefore, one might speculate that selective targeting of host Mediator subunits using small molecules (e.g., CDK8 inhibitors; (Hofmann et al., 2020; Solum et al., 2020) ) could be leveraged as a therapy to disrupt SARS-CoV-2 infection (Bancerek et al., 2013; Napoli et al., 2012; Spaeth et al., 2011) . Beyond well-characterized pathways represented by multiple components, we also identified factors with less understood network-level connections, including the DHX36 and DHX38 DEAH-Box helicases, the GOLGA6L1 and GOLGA8O Golgin family proteins, the TRMT5 and TRMT6 TRNA methyltransferases, the GPR89A and GPR89B G protein-coupled receptors, the TMED2 and TMED10 Transmembrane P24 trafficking proteins, and a pair of genes involved in phosphatidylethanolamine biosynthesis, such as PCYT2 and EPT1, among others ( Figure 3A and Table S1 ). Further mining of this SARS-CoV-2 host factor essentiality compendium could expand the repertoire of potential targetable factors to treat COVID-19. The compendium of human factors co-opted by the HCoV-NL63 and HCoV-229E alphacoronaviruses significantly differs from that of the SARS-CoV-2 and HCoV-OC43 betacoronaviruses ( Figure 3A) . For instance, HCoV-NL63 seems particularly dependent on chromatin regulators with known functional interactions, including the KDM6A/UTX histone demethylase, the KMT2D/MLL4 histone methyltransferase, and the EP300 histone acetyltransferase, raising the interesting possibility that HCoV-NL63 co-opts the well established UTX-MLL4-EP300 enhancer remodeling network (Wang et al., 2017) to reprogram the transcriptome of the host for successful infection (Figure 3A) . On the other hand, HCoV-229E seems particularly dependent on HOPS complex proteins, including VPS11 and RAB7A ( Figure 3A ) (Balderhaar and Ungermann, 2013) . These results demonstrate that coronaviruses from the same genera, including the HCoV-NL63 and HCoV-229E alphacoronaviruses, can employ different host factor pathways during infection. By integrating our Coronaviridae screening data with additional Zika virus and yellow fever virus CRISPR screening data (Hoffmann & Schneider et al., ; see accompanying manuscript), we identified TMEM41B as a critical host factor for infection by SARS-CoV-2, HCoV-OC43, HCoV-NL63, and HCoV-229E. TMEM41B is a poorly understood ER-localized transmembrane protein that was recently shown by three independent groups to regulate autophagy in conjunction with VMP1 (Moretti et al., 2018; Morita et al., 2018; Shoemaker et al., 2019) . Strikingly, TMEM41B was the only autophagy-related gene that scored as a significant hit across the SARS-CoV-2, HCoV-OC43, and HCoV-229E CRISPR screens ( Figure 4A) , and it was subsequently validated as a co-factor for HCoV-NL63 as well ( Figure 4C ). This suggests a putative autophagy-independent role for TMEM41B as a pan-coronavirus replication factor. Moreover, our functional and mechanistic work showing that TMEM41B is a required host factor for infection by more than ten flaviviruses (Hoffmann & Schneider et al., ; see accompanying manuscript) suggested that TMEM41B is the only human protein that is critical for infection by both virus families. Thus, TMEM41B is a critical host factor required for infection by all of the coronaviruses tested in our study, as well as several other viruses of high public health interest, representing an attractive target for further investigation and development of antiviral therapies. Coronavirus host factor discovery and validation is an active area of research with multiple studies appearing on preprint servers in recent months (Baggen et al., 2020; Heaton et al., 2020; Hoffmann et al., 2020a; Wang et al., 2020; Wei et al., 2020; Zhu et al., 2020b) . Wei et al., performed genome-wide CRISPR screens in the African green monkey cell line Vero-E6 and reported strong dependency on screen in A549 cells engineered to express ACE2 and identified serine/arginine-rich protein-specific kinase 1 (SRPK1) as a single dominant hit that is unique to their screen (Heaton et al., 2020) . They showed that an SRPK1/2 inhibitor was inhibitory to HCoV-229E and SARS-CoV-2 at 17-53 µM in vitro, a concentration well above the Ki for SRPK1 with unknown consequences to cell viability. Like Heaton et al., Zhu et al. , performed a similar screen using A549-ACE2 cells (Zhu et al., 2020b) . However, in contrast to Heaton et al., they identified known host factors such as ACE2 and CTSL, as well as elements of the retromer complex, the COMMD/CCDC22/CCDC93 (CCC) complex, the Wiskott-Aldrich syndrome protein and SCAR homologue (WASH) complex, the actin-related proteins-2/3 (Arp2/3) complex and others, but not SRPK1. More recently, Wang et al., performed a series of screens using Huh7.5.1-ACE2-IRES-TMPRSS2 cells . Of note, Huh7.5.1 cells do not express ACE2 in contrast to the parental Huh-7.5 cells used in the present study. Wang et al., identified four significant host factors, one of which was SCAP, validating our prior finding that SCAP plays an important role in coronavirus infection (Hoffmann et al., 2020a) . The remaining three significant host factors were also identified in our study: TMEM106B, VAC14, and ACE2. By contrast, our study identified 128 high-confidence host factors, perhaps in part due to our inclusion of multiple replicates inhibitors across multiple coronaviruses, although the mechanism of action for SARS-CoV-2 is unclear as PIK3C3 appeared to be dispensable for SARS-CoV-2 based on their results and on the present study, although it does appear essential for HCoV-229E and HCoV-OC43 in multiple studies described above. The results of this study should be interpreted within the context of its limitations. If a gene did not score in our screens, it does not rule out that gene being an important SARS-CoV-2 factor for a number of reasons. First, pooled CRISPR screens may not identify functionally redundant or buffering genes (Ewen-Campen et al., 2017) . Second, Huh-7.5 cells were chosen based on their infectivity by multiple coronaviruses; however, it should be understood that they are not airway cells. Nevertheless, a recent study demonstrated that hits in Huh-7 cells translate to human cells of lung origin (Baggen et al., 2020) . Furthermore, as shown in Figure S6 , the vast majority of genes identified here are expressed in human cells and tissues known to be infected by SARS-CoV-2. Lastly, our current experimental system is limited to assessing survival and can not interrogate host factors that act in late stages of the viral life cycle, nor can it identify genes that play important roles in immune modulation and pathogenesis. It is essential to understand the underlying biology of a disease in order to develop new strategies for treatment and prevention. For infectious diseases, this entails studying the biology of the pathogen and the host. We identified complex, interconnected networks of coronavirus host factors and pathways that are essential for virus infection, nominating hundreds of new host proteins that represent liabilities for SARS-CoV-2 and potential opportunities for therapeutic intervention. This represents the most extensive functional catalog of host factors required for infection by SARS-CoV-2 and three seasonal coronaviruses (HCoV-229E, HCoV-NL63, and HCoV-OC43) to date, providing a larger context in which to interpret ongoing and future large scale CRISPR studies. Future efforts will focus on dissecting the complex interplay between virus and host and direct medicinal chemistry and drug repurposing resources toward the most chemically-tractable targets. This work was initiated and conducted under unusual circumstances. As New York City and much of the world was sheltering in place to reduce the spread of SARS-CoV-2, all of the authors here were sustained during the shutdown by generous funding intended for related and unrelated work. During this time we were fortunate to obtain funding from government and charitable agencies that allowed this COVID-19 work to continue. For funding directly related to these COVID-19 efforts, we thank the Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contacts, John T. Poirier (John.Poirier@nyulangone.org) and Charles M. Rice (ricec@mail.rockefeller.edu). To generate stable Cas9-expressing cell lines, we used lentiCas9-Blast (Addgene, cat. #52962). To Production and titration of coronavirus stocks SARS-CoV-2 (strain: USA-WA1/2020) and HCoV-NL63 were obtained from BEI Resources (NR-52281 and NR-470). HCoV-OC43 was obtained from ZeptoMetrix (cat. #0810024CF) and HCoV-229E was generously provided by Volker Thiel (University of Bern). All viruses were amplified at 33 °C in Huh-7.5 cells to generate a P1 stock. To generate working stocks, Huh-7.5 cells were infected at a multiplicity of infection (MOI) of 0.01 plaque forming unit (PFU)/cell (SARS-CoV-2, HCoV-NL63, HCoV-OC43) and 0.1 PFU/cell (HCoV-229E) and incubated at 33 °C until virus-induced CPE was observed. Supernatants were subsequently harvested, clarified by centrifugation (3,000 g × 10 min) at 4 dpi (HCoV-229E), 6 dpi (SARS-CoV-2, HCoV-OC43) and 10 dpi (HCoV-NL63), and aliquots stored at -80 °C. Viral titers were measured on Huh-7.5 cells by standard plaque assay. Briefly, 500 µL of serial 10-fold virus dilutions in Opti-MEM were used to infect 4 x 10 5 cells seeded the day prior into wells of a 6-well plate. After 90 min adsorption, the virus inoculum was removed, and cells were overlaid with DMEM containing 10% FBS with 1.2% microcrystalline cellulose (Avicel). Cells were incubated for 4 days (HCoV-229E), 5 days (SARS-CoV-2, HCoV-OC43) and 6 days (HCoV-NL63) at 33 °C, followed by fixation with 7% formaldehyde and crystal violet staining for plaque enumeration. All SARS-CoV-2 experiments were performed in a biosafety level 3 laboratory. To confirm the identity of the viruses, RNA from 200 µl of each viral stock was purified by adding 800 µl TRIzol™ Reagent (ThermoFisher Scientific, cat. #15596026) plus 200 µl chloroform then centrifuged at 12,000 g x 5 min. The upper aqueous phase was moved to a new tube and an equal volume of isopropanol was added. This was then added to an RNeasy mini kit column (Qiagen, cat. #74014) and further purified following the manufacturer's instructions. Viral stocks were confirmed via next generation sequencing at the NYU Genome Technology Center using an Illumina stranded TruSeq kit and omitting the polyA selection step. Libraries were then sequenced by MiSeq Micro (2 x 250 bp paired end reads). Infection of TMEM41B knockout cells with SARS-CoV-2, HCoV-OC43, HCoV-NL63, and HCoV-229E Huh-7.5 TMEM41B knockout cells (KO) and their reconstituted (tagRFP-TMEM41B) counterpart were generated as described in (Hoffmann & Schneider et al., ; see accompanying manuscript). The day prior to infection, Huh-7.5 WT, TMEM41B KO and reconstituted KO cells were seeded into 96-well plates at different densities relative to time of fixation e.g., 1x10 4 , 7.5x10 3 and 5x10 3 cells/well for a 24, CRISPR-Cas9 genetic screening Huh-7.5-Cas9 cells were generated by lentiviral transduction of lentiCas9-Blast (Addgene, cat. #52962) followed by selection and expansion in the presence of 5 µg/ml blasticidin. The human CRISPR Brunello library (Doench et al., 2016b) was obtained through Addgene as a ready-to-use lentiviral pooled library at a titer ≥ 1×10 7 TU/mL (Addgene, cat. #73178-LV). To deliver the Brunello sgRNA library, 2.04 x 10 8 Huh-7.5-Cas9 cells were transduced by spinoculation at 1,000 g x 1 h in media containing 4 µg/ml polybrene (Millipore, cat. #TR-1003-G) and 20 mM HEPES (Gibco, cat. #15630080) at a MOI = 0.21 to achieve ~560-fold overrepresentation of each sgRNA. Cells were spinoculated at 3 x 10 6 cells/well in 12-well plates in 1.5 ml final volume. Six hours post transduction, cells were trypsinized and transferred to T175 flasks at 7 x 10 6 cells/flask. Two days later, media was replaced with fresh media containing 1.5 µg/ml puromycin and cells were expanded for five additional days prior to seeding for coronavirus infection. Huh-7.5-Cas9 cells transduced with the Brunello sgRNA library were seeded in p150 plates at 4.5 x 10 6 cells/plate with two plates per replicate (e.g., 9 x 10 6 cells) and three replicates for each condition (mock, HCoV-229E, HCoV-NL63, HCoV-OC43). For biosafety reasons, SARS-CoV-2 infection was performed in T175 screw top flasks. For infections at 37 ºC, we seeded cells at 5 x 10 6 cells per flask and used two flasks (e.g., 1 x 10 7 cells) per replicate. For infections at 33 ºC, we seeded cells at 6.7 x 10 6 cells per flask and used three flasks (e.g., 2 x 10 7 cells) per replicate. Both SARS-CoV-2 screens were performed in triplicate. The following day, the media was removed and viruses diluted in 10 ml/plate OptiMEM were added to cells. The inocula of HCoV-229E, HCoV-NL63 and SARS-CoV-2 were supplemented with 1 µg/ml TPCK-treated trypsin (Sigma-Aldrich, cat. #T1426) increasing the rate of infection. After two hours on a plate rocker at 37 ºC, 10 ml/plate media was added and plates were moved to 5% CO2 incubators set to 33 °C (HCoV-229E, Analysis of CRISPR-Cas9 genetic screen data FASTQ files were processed and trimmed to retrieve sgRNA target sequences followed by enumeration of sgRNAs in the reference sgRNA library file using MAGeCK (Li et al., 2014) . MAGeCK was also used to determine gene essentiality (beta) using its maximum likelihood estimation (MLE) algorithm. Zscores for visualization in the form of heatmaps were computed using the following approach: for each condition, the log2 fold change with respect to the initial condition was computed. A natural cubic spline with 4 degrees of freedom was fit to each pair of infected and control cells and residuals were extracted. To obtain gene-wise data, the mean residuals for each group of sgRNAs was calculated, a z-score was computed, and a p-value was determined using a 2-sided normal distribution test. P-values were combined across screens using Fisher's sumlog approach and corrected for multiple testing using the method of Benjamini & Hochberg. Functional clustering and network analysis of screening data High confidence CRISPR hits with FDR cutoffs below 0.05 were extracted for functional clustering and network building. Briefly, enriched pathways were identified from the NIH NCATS BioPlanet database , which aggregates currates pathways from multiple sources, using competitive gene set testing of z scores in pre-ranked mode (Wu and Smyth, 2012) . For construction of the network in Figure 3 , significant CRISPR hits from any virus were searched using the STRING database (stringdb.org) (Szklarczyk et al., 2019) using default parameters and imported into Cytoscape (Shannon et al., 2003) . Overlapping hits per virus were calculated and subsequently depicted as pie charts per node in Adobe Illustrator. For virus specific networks in Figure S2 , significant CRISPR hits per virus and the next adjacent 100 interactors were extracted and graphed in Cytoscape. (Stuart et al., 2019) . Statistical tests were used as indicated in the figure legends. Generation of plots and statistical analyses were performed using the R statistical computing environment. Error bars represent standard deviation, unless otherwise noted. We used Student's t-test (unpaired, two-tailed) to assess significance between treatment and control groups, and to calculate P values. P < 0.05 was considered statistically significant. Data supporting the findings of this study are reported in Supplementary Figures S1-S6 and Tables S1-S2. All raw data corresponding to CRISPR screens will be available through NCBI GEO. Networks are available on NDEx. All reagents and materials generated in this study will be available to the scientific community through Addgene and/or MTAs. Chen, B., Gilbert, L.A., Cimini, B.A., Schnitzbauer, J., Zhang, W., Li, G.-W., Park, J., Blackburn, E.H., Weissman, J.S., Qi, L.S., et al. (2013) . HS3ST1 HS3ST3B1 B3GAT3 B3GAT2 GLCE B3GAT1 B3GALT6 HS3ST5 HS3ST2 EXT1 EXT2 B4GALT7 HS3ST3A1 XYLT1 XYLT2 HS6ST1 HS6ST2 HS2ST1 HS6ST3 NDST3 EXTL1 NDST2 EXTL3 NDST1 EXTL2 NDST4 VAC14 MTMR2 MTMR4 PIKFYVE PIK3R4 PIK3C3 PIK3C2A MTMR7 MTM1 FIG4 SEMA6D GPLD1 PLAUR DPM1 DPM2 PIGC DPM3 PIGF PIGB PIGA PIGL PIGK PIGN PIGM PIGH PIGG PIGT PIGS PGAP1 PIGV PIGU PIGP PIGO PIGQ GPAA1 PIGX PIGW HCoV-NL63 HCoV-OC43 FDPS MVK SREBF1 IDI1 IDI2 SREBF2 CYP51A1 HMGCS1 GGPS1 LSS HMGCR HSD17B7 DHCR24 MSMO1 TM7SF2 SQLE EBP NSDHL PMVK SC5D LBR MVD DHCR7 FDFT1 CSDE1 SCAP FAM98A NPC2 RAB10 BRD4 GNG5 RAB7A ALG5 HECTD1 PABPC1 SBNO1 TUBGCP2 NUTF2 VPS11 VPS39 RAB2A EMC1 PIGS GPAA1 ATP6AP1 CSNK2B BCS1L ATP6V1A NOL10 RPL36 DDX10 SRP54 SEPSECS CYB5B RTN4 ALG8 G3BP1 MOGS RAB8A COLGALT1 AP2M1 HS2ST1 EIF4E2 GIGYF2 PIGO COMT DDX21 INTS4 MEPCE RAE1 RAB14 RHOA LARP7 CSNK2A2 ZYG11B DCAF7 DHX36 MBTPS1 SLC35B2 TMEM106B TMEM41B MBTPS2 EXT2 VAC14 EXTL3 B4GALT7 EXT1 RGP1 SREBF2 SCAP HS2ST1 COG4 MED15 TM9SF3 GPR89A MED12 GPR89B EPT1 HMGCS1 XYLT2 EP300 HSCB RTCB HIRA CDIPT CSNK2B B3GALT6 GDI2 COG3 UBE3D TADA1 RAB6A EXOC2 DCPS RPP21 TAF6L NDST1 CMPK1 TOM1 TMED10 MGAT1 N6AMT1 JAGN1 TTC4 MED23 SNRNP40 B3GAT3 COG2 COG7 COG8 TMED2 PYROXD1 TRIM28 PCYT2 BRAT1 RASL10A TRMT61A PDS5B JTB LCMT1 MED24 EXOC1 WDR73 XPO5 VRK1 MON2 CTSL DOHH SAR1A PPP2R2A GTF3C6 CDX2 SLC30A1 SRSF5 PGGT1B DDX1 COASY LUC7L2 EGLN1 KCNJ4 GIGYF2 DPH6 MED16 RAB10 MVK ASUN DGCR8 PMVK BMPR1A CARD10 GLCE BRE CABIN1 TOE1 EXOC4 YRDC USO1 SAFB TAF1B TRMT5 PPP2CA SLC39A9 MSMO1 DHPS VHL ALG6 HNF4A ATP2C1 CSK DOLK DEGS1 TRMT6 CLEC16A MTCH2 ACE2 ZFX MED10 CENPO GTF3C5 EWSR1 DOLPP1 ANPEP TMEM41B RTCB NRIP1 GNPTAB RAB7A GPR89A SPNS1 PIK3C3 FIG4 CDX2 VPS11 CCZ1B UVRAG GPR89B RABL3 TFAP4 ZFP36L2 FBXO11 SELPLG VMP1 CDX2 ACE2 BMPR1A EP300 SMAD4 NRIP1 ELF3 MED23 ACVR1 SETDB1 USP22 CITED2 KMT2D HNF4A ATXN7L3 MEN1 MED24 HNF1B SENP1 SIAH1 KLF5 ZFP36L2 KDM6A SMG9 EGLN1 SMAD5 FAM60A ATF7IP NFKB1 PATZ1 ZNF592 GATA6 PLAC8 CRYBB1 MBOAT2 SPRY4 LMO4 HELZ PTMS GPAA1 THAP7 PAXIP1 EXT1 EXT2 XYLT2 SLC35B2 B3GAT3 B4GALT7 EXTL3 TM9SF3 B3GALT6 SLC39A9 NDST1 COG3 VPS11 CDX2 COG5 UGDH COG2 FIG4 GNPTAB VPS16 RAB7A PIK3C3 VPS33A CCZ1B CCZ1 PTAR1 COG7 VPS39 EMC4 COG4 EMC1 MMGT1 GALE UNC50 MBTPS1 TMEM41B RAB2A VAC14 DPH3 C18orf8 VPS18 EMC2 PIGO ARL1 SCAP EMC6 BMPR1A UVRAG RTCB PIGP DDX1 MBTPS2 EIF4A1 SAR1A FAM20B COG6 COG1 MSMO1 PIGX COG8 SPNS1 NUDCD2 JAGN1 TM9SF2 DPH6 GPR89A MFSD12 PIGC ZFP36L2 NRIP1 VPS41 UFSP2 UBE3D CANT1 ZNF266 UGP2 DPH5 ARMC5 MON2 ELP5 KIAA1109 MON1B GPR89B DUSP11 KIAA1683 (A) Genome-wide CRISPR screening workflow. Cas9-expressing Huh-7.5 cells are transduced with the Brunello genome-wide CRISPR library, selected with puromycin, and infected with SARS-CoV-2 or one of three season coronaviruses (HCoV-OC43, HCoV-NL63, or HCoV-229E). Surviving cells along with mock controls are then harvested and sgRNA abundance is determined using next-generation sequencing. (B) Bubble plot of data from SARS-CoV-2 screens at 37 ºC. Red lines denote z = ± 2. (C) Bubble plot of data from SARS-CoV-2 screens at 33 ºC. Red lines denote z = ± 2. (D) Scatterplot comparing z-scores from (B) and (C) for SARS-CoV-2 screens at 37 ºC and 33 ºC, respectively. (E) Subset of significantly enriched genes from SARS-CoV-2 screens at 37 ºC and 33 ºC. Table S1. CRISPR screen results. Table S1A : Huh-7.5 37 ºC SARS-CoV-2 z scores. Table S1B : Huh-7.5 33 ºC SARS-CoV-2 z scores. Table S1C : Huh-7.5 33 ºC HCoV-OC43 z scores. Table S1D : Huh-7.5 33 ºC HCoV-NL63 z scores. Table S1E : Huh-7.5 33 ºC HCoV-229E z scores. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4 The Mediator complex: a central integrator of transcription Rab10 associates with primary cilia and the exocyst complex in renal epithelial cells Identification of TMEM106B as proviral host factor for SARS-CoV-2. bioRxiv Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6) CORVET and HOPS tethering complexes -coordinators of endosome and lysosome fusion CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon Response Maintaining order: COG complex controls Golgi trafficking, processing, and sorting Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro Mevalonate pathway: a review of clinical and therapeutical implications Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 Heterologous expression and biochemical characterization of soluble human xylosyltransferase II The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate Molecular Evolution of Human Coronavirus Genomes Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence Human papillomavirus infection requires cell surface heparan sulfate Regulation of the mevalonate pathway A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Interaction network of SARS-CoV-2 with host receptome through spike protein. bioRxiv Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2. bioRxiv Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance The NCATS BioPlanet -An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes The L1 major capsid protein of human papillomavirus type 11 recombinant viruslike particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion Heparan Sulfate Biosynthesis Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens The Exocyst Complex in Health and Disease Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans The exocyst complex TMEM41B is a novel regulator of autophagy and lipid mobilization Genome-wide CRISPR screen identifies TMEM41B as a gene required for autophagosome formation TMEM41B functions with VMP1 in autophagosome formation Unraveling framework of the ancestral Mediator complex in human diseases The Importance of Heparan Sulfate in Herpesvirus Infection Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycanprotein linkage region of proteoglycans Flavivirus entry receptors: an update tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans A CRISPR toolbox to study virus-host interactions A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection Characterization of the influence of mediator complex in HIV-1 transcription Identification of Zika Virus and Dengue Virus Dependency Factors using Cytoscape: a software environment for integrated models of biomolecular interaction networks CRISPR screening using an expanded toolkit of autophagy reporters identifies TMEM41B as a novel autophagy factor Role of the conserved oligomeric Golgi (COG) complex in protein glycosylation New CDK8 inhibitors as potential antileukemic agents -Design, synthesis and biological evaluation Mediator and human disease Comprehensive Integration of Single-Cell Data STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus Disparate temperature-dependent virus -host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium. bioRxiv Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 Functional genomic screens identify human host factors for SARS-CoV-2 A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection The Exocyst at a Glance Camera: a competitive gene set test accounting for inter-gene correlation Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans Human aminopeptidase N is a receptor for human coronavirus 229E In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 A pneumonia outbreak associated with a new coronavirus of probable bat origin A Novel Coronavirus from Patients with Pneumonia in China The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission. bioRxiv